Literature DB >> 26432852

Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.

David Kremer1, Hans-Peter Hartung2, Patrick Küry1.   

Abstract

Entities:  

Keywords:  Multiple sclerosis; neuroregeneration; semaphorin 3A; semaphorin 7A

Mesh:

Substances:

Year:  2015        PMID: 26432852     DOI: 10.1177/1352458515608693

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  PLXNA3 Variant rs5945430 is Associated with Severe Clinical Course in Male Multiple Sclerosis Patients.

Authors:  Moaz Qureshi; Mohamed Hatem; Raed Alroughani; Sindhu P Jacob; Rabeah Abbas Al-Temaimi
Journal:  Neuromolecular Med       Date:  2017-05-23       Impact factor: 3.843

Review 2.  Emerging role of semaphorin-3A in autoimmune diseases.

Authors:  Li-Na Liu; Xiao-Mei Li; Dong-Qing Ye; Hai-Feng Pan
Journal:  Inflammopharmacology       Date:  2018-04-25       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.